Clinical Updates
REMOVAL OF CODEINE FROM THE MARKET
In its January 10, 2014 notice in the Federal Register, the FDA ordered drug companies…
Generic Detrol LA Capsules®
On Thursday, January 2, Teva Pharmaceuticals launched the generic equivalent of Detrol LA® extended-release capsules…
Cymbalta® Delayed-Release Capsule Launch
Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released,…
Launch of Generic Aciphex® 20mg Tablets
On Friday, November 8, Lupin Pharmaceuticals, Inc., launched the generic equivalent of Aciphex® delayed-release tablets…
FDA Approval for ZORVOLEX™
October 18, 2013 – Iroko Pharmaceuticals, LLC, announced that the FDA had approved ZORVOLEX™ (diclofenac)…
Launch of Generic Niaspan® Extended-Release Tablets
Teva Pharmaceuticals has launched generic Niaspan® Extended-Release Tablets, which received FDA Approval in April 2005…
Generic Lidoderm 5% Patch Launches
Actavis Pharma, Inc. has launched generic Lidoderm® (lidocaine patch 5%), which received FDA approval on…
Generic Trilipix Capsules Launch
On July 15, 2013, Global Pharmaceuticals received final FDA approval and commenced shipping for generic…
Generic Zomig Launches
On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT…
FDA Bans Generic Version of Oxycontin
On the day when the patent for the original version of OxyContin was set to…
